Search Results 211-220 of 18114 for CLL

  1. Clinical trials - Oncology (Medical)

    All study subjects will receive acalabrutinib, durvalumab, and venetoclax. Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small ...

  2. A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Subjects With Lymphoma or Chronic Lymphocytic Leukemia - Mayo Clinic

    ... Chronic Lymphocytic Leukemia. Print details. Share; Facebook · Twitter ... CLL. Globally, 265 subjects may be enrolled into 4 treatment arms, including ...

  3. Resources - B-Cell Lymphoproliferative Disorders - Mayo Clinic Research

    Slager's B-Cell Lymphoproliferative Disorders Laboratory, including information about chronic lymphocytic leukemia, lymphoma, multiple myeloma, the National ...

  4. Oncology (Medical) - Clinical trials

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...

  5. Clinical trials - Oncology (Medical)

    ... chronic lymphocytic leukemia (CLL). It is composed of a patient survey (n=250), a physician survey (n=100), and a practice survey completed by each site ...

  6. Bone Marrow Transplant Program - Clinical trials

    ... chronic lymphocytic leukemia (CLL) in comparison to age-matched healthy control (HC) donors. A Study to Evaluate the Role of Gut Microbiome in Cancer ...

  7. Spinal Cord Lymphoma Clinical Trials - Mayo Clinic Research

    ... Chronic Lymphocytic Leukemia (CLL) with controls from a normal household and age-matched population. A Study of Nivolumab in Relapsed/Refractory Primary ...

  8. Hematology - Clinical trials

    A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).

  9. Exploring the Role of B-cell Activating Factor Receptor (BAFFR)-based Chimeric Antigen Receptor T-cell (CAR T) in BAFFR-expressing B-cell Hematologic Malignancies and Autoimmune Rheumatologic Disorders - Mayo Clinic

    ... chronic lymphocytic leukemia (CLL) and B-cell acute lymphoblastic leukemia (B-cell ALL) using primary tumor and/or patient derived xenograft models, and to ...

  10. Oncology (Medical) - Clinical trials

    ... chronic lymphocytic leukemia (CLL). This study will also allow participants who are currently progressing on a Bruton tyrosine kinase inhibitor (BTKi) and ...